Related Experiment Videos
Is there a metabolic basis for the fibrositis syndrome?
Abstract:
Patients with the fibrositis syndrome experience moderately severe musculoskeletal discomfort, mood changes associated with nonrestorative sleep, and tenderness to palpation at specific body sites. There is no characteristic abnormal laboratory finding in these patients to help identify the population. A report by Moldofsky and Warsh (Pain 1978; 5: 65-71) of low serum levels of free tryptophan in patients with severe fibrositis syndrome is intriguing but remains unexplained. Those data plus the observation by Hudson et al (Am J Psychiatry 1985; 142: 441-446; Biol Psychiatry 1984; 19: 1489-1493) that patients with fibrositis syndrome exhibit an increased prevalence of anxiety and depression suggest a number of possible avenues for further study. They include potential alterations in the homeostasis of catecholamines, corticosteroids, serotonin, aromatic amino acids, platelet membrane receptor levels, and the activity of platelet membrane monoamine oxidase. Among these possibilities, evidence is now available that suggests an increased production of catecholamines in fibrositis syndrome.
Insights
Fibrositis syndrome patients experience pain and sleep issues. New evidence suggests increased catecholamine production may be a key factor in this condition.
Area of Science:
- Rheumatology
- Neuroscience
- Psychiatry
Background:
- Fibrositis syndrome is characterized by musculoskeletal pain, mood changes, and nonrestorative sleep.
- No specific laboratory findings currently identify fibrositis syndrome patients.
- Previous research suggests low tryptophan and increased anxiety/depression in affected individuals.
Purpose of the Study:
- To explore potential biochemical alterations in fibrositis syndrome.
- To investigate the role of catecholamines, serotonin, and other factors in the condition's pathophysiology.
Main Methods:
- Review of existing literature and case studies.
- Analysis of biochemical pathways potentially involved in fibrositis syndrome.
Main Results:
- Evidence suggests an increased production of catecholamines in patients with fibrositis syndrome.
- Potential alterations in aromatic amino acid metabolism and monoamine oxidase activity warrant further investigation.
Conclusions:
- Increased catecholamine production is a significant finding in fibrositis syndrome.
- Further research into neurotransmitter systems may reveal new diagnostic and therapeutic targets.